MedTrace Logo

Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)

NCT02714114 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2017-06-15

No results posted yet for this study

Summary

The aim of the study is to develop robust analytical protocols for first-void urine sample preparation and antibody assays to monitor natural and/or vaccine induced immunity against HPV (Human Papillomavirus).

Conditions

  • Human Papilloma Virus Infection

Interventions

OTHER

First-void urine collection

One time collection of ca. 20ml of first-void urine (i.e. the initial stream of the urine void) with the Colli-PeeTM device (Novosanis).

OTHER

Blood draw

One time blood sample collection (5-10 cc) by a study nurse of Centre for the Evaluation of Vaccinations (CEV).

Sponsors & Collaborators

  • Research Foundation Flanders

    collaborator OTHER

  • Universiteit Antwerpen

    lead OTHER

Principal Investigators

  • Pierre Van Damme, Prof MD PhD · Universiteit Antwerpen

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02714114 on ClinicalTrials.gov